跳至主要内容
临床试验/CTRI/2023/10/059323
CTRI/2023/10/059323尚未招募4 期

A retrospective, multicentre, observational registry in patients treated with Myval™ Transcatheter Heart Valve System in real-world settings. - Myval THV Registry

Meril Diagnostics Private Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Patients treated with the Myval THV system for the following conditions:
  • Symptomatic heart disease due to failure (stenosed, insufficient, or
  • combined) of a surgical bioprosthetic aortic valve or mitral valve
  • Symptomatic heart disease due to failure of native bicuspid aortic
  • Symptomatic heart disease due to failure of the pulmonic valve
  • Patients with calcific native mitral valve stenosis with mitral annular
  • calcification
  • Patients with failing surgical rings in the mitral position with mitral
  • regurgitation or stenosis
  • Patients who underwent tricuspid valve replacement (valve-in-valve)
  • or prior TV repair (valve-in-ring)
  • Patients who underwent Transcatheter Pulmonary Valve
  • Replacement in pre-stented Right Ventricular Outflow Track (RVOT).

排除标准

  • As this is a retrospective review of data, there are no formal exclusion criteria for this study.

研究者

发起方
Meril Diagnostics Private Limited

相似试验

To assess the safety and performance of the Myval™... | 临床试验